Effect of salvianolic acid B on Smad3 expression in hepatic stellate cells

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 1, 2004, Pages 102-105

  Zhao, Jun Fang ^a   Liu, Cheng Hai ^a   Hu, Yi Yang ^a   Xu, Lie Ming ^a   Liu, Ping ^a   Liu, Cheng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Liver fibrosis; Salvianolic acid B; Smads; Transforming growth factor

Indexed keywords

COLLAGEN TYPE 1; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID B; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INCUBATION TIME; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION; STELLATE CELL; SUPERNATANT; WESTERN BLOTTING;

ANIMALS; BENZOFURANS; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN TYPE I; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATOCYTES; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 1342308460     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Madro, A, Slomka M, Celinski K, Chibowski D, Czechowska G, Kleinrok Z, et al. The influence of interferon alpha on the rat liver injured by chronic administration of carbon tetrachloride. Ann Univ Mariae, Curie Sklodowska 2002;57:55-60.
2. Nakaji M, Hayashi Y, Ninomiya T, Yano Y, Yoon S, Seo Y, et al. Histological grading and staging in chronic hepatitis: its practical correlation. Pathol Int 2002;52:683-690.
3. Giannelli G, Quaranta V, Antonaci S. Tissue remodelling in liver diseases. Histol Histopathol 2003;18:1267-1274.
4. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003;124:147-159.
5. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001;21:373-384.
6. Liu C, Liu P, Hu. YY, Zhu DY. Effects of salvianolic acid-B on TGF-beta 1 stimulated hepatic stellate cell activation and its intracellular signaling. Chin J Med 2002;82:1267-1272.
7. Pietrangelo A. Iron-induced oxidant stress in alcoholic liver fibrogenesis. Alcohol 2003;30:121-129.
8. Segawa M, Kayano K, Sakaguchi E, Okamoto M, Sakaida I, Okita K. Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen alpha 2(I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-beta. Hepatol Res 2002;24:305.
9. Lee KS, Lee SJ, Park HJ, Chung JP, Han KH, Chon CY, et al. Oxidative stress effect on the activation of hepatic stellate cells. Yonsei Med J 2001;42:1-8.
10. Liu CH, Hu YY, Liu P, Liu C. Transforming growth β1 and liver fibrosis. Chin J Hepatol 1996;4:51-54.
11. Leyland H, Gentry J, Arthur MJ, Benyon RC. The plasminogen-activating system in hepatic stellate cells. Hepatology 1996; 24:1172-1178.
12. Chen P, Zhai W, Zhang Y, Zhang J, Gu Y. Effects of hypoxia on expression and activity of matrix metalloproteinase-2 in hepatic stellate cell. Chin J Hepatol 2000;8:276-278.
13. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001;21:373-384.
14. Roth S, Michel K, Gressner AM. Transforming growth factor-beta in liver arenchymal cells, its injury-dependent release and paracrine effects on hepatic stellate cells. Hepatology 1998;27: 1003-1012.
15. Liu CH, Gaca MD, Swenson ES, Vellucci VF, Reiss M, Wells RG. Smads 2 and 3 are differentially activated by TGF-β in quiescent and activated hepatic stellate cells: constitutive nuclear localization of Smads in activated cells is TGF-β independent. J Biol Chem 2003;278:11721-11728.
16. Yata Y, Gotwals P, Koteliansky V, Rockey DC. Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology 2002;35:1022-1030.
17. Yao XX, Tang YW, Yao DM, Xiu HM. Effects of Yigan Decoction on proliferation and apoptosis of hepatic stellate cells. World J Gastroenterol 2002;8:511-514.
18. Yang L, Chen D, Zhang Z, Qiang O. Inhibition of the activation and collagen production of cultured rat hepatic stellate cells by antisense oligonucleotides against transforming growth factor-beta 1. Hua Xi Yi Ke Da Xue Xue Bao 2000;31:42-45.
19. George J, Roulot D, Koteliansky VE, Bissell DM. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA 1999; 96: 12719-12724.
20. Liu P, Hu YY, Liu C, Liu CH, Xu LM. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002;8:679-685.
21. Alpini G, Aragona E, Dabeva M, Salvi R, Shafritz DA, Tavoloni N. Distribution of albumin and alpha-fetoprotein mRNA in normal, hyperplatic and preneoplastic rat liver. Am J Pathol 1992;141:623-632.
22. Bissell DM. Hepatic fibrosis as wound repair: a progress report. J Gastroenterol 1998;33:295.
23. Dooley SB, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM. Modulation of transforming growth factor 1 response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 2000; 31: 1094-1106.
24. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-β responses. Cell 1998;956:737-740.
25. Massague J. TGF-β signal transcription. An Rev Biochem 1998;67:753-791.
26. Zhao JF, Liu C, Liu CH. Cytoplasmic signaling of transforming growth factor β and Smads protein. Chin J Pathol Physiol 2002;18:321-325.
27. Schnabl B, Kweon YO, Frederick JP. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001;34:89-100.
28. Inagaki Y, Nemoto T, Nakao A, Dijke PT, Kobayashi K, Takehara K, et al. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J Biol Chem 2001;276:16573-16579.
29. Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003; 38:879-889.
30. Inagaki Y, Mamura M, Kanamatu Y, Greenwel P, Nemoto T, Takehara K, et al. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol 2001;187:117-123.